Retour
Fourchette du Jour
12,07 €
12,77 €
Fourchette 52 Semaines
3,91 €
19,11 €
Volume
813 813
Moyenne 50J / 200J
15,09 €
/
13,15 €
Clôture Précédente
12,83 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (627 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | -4,5 | 0,3 |
| P/B | 3,4 | 2,9 |
| ROE % | -72,2 | 3,7 |
| Net Margin % | -739,4 | 3,8 |
| Rev Growth 5Y % | -4,0 | 10,0 |
| D/E | 0,1 | 0,2 |
Objectif de Cours des Analystes
Hold
37,50 €
+197.9%
Low: 36,00 €
High: 39,00 €
BPA Prévisionnel
-3,22 €
CA Est.
3,8 M
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2030 |
2,88 €
0,54 € – 5,21 €
|
880 M | 5 |
| FY2029 |
0,87 €
0,17 € – 1,58 €
|
570 M | 2 |
| FY2028 |
-1,17 €
-2,25 € – 0,31 €
|
290 M | 7 |
Points Clés
Revenue declined -4,00% annually over 5 years
Debt/Equity of 0,07 — conservative balance sheet
Negative free cash flow of -243,39M
Revenue growth is decelerating — 1Y growth trails 5Y average by 23,50%
Croissance
Revenue Growth (5Y)
-4,00%
Revenue (1Y)-27,50%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Qualité
Return on Equity
-72,19%
ROIC-55,85%
Net Margin-739,42%
Op. Margin-775,98%
Sécurité
Debt / Equity
0,07
Current Ratio8,88
Interest Coverage7376,79
Valorisation
P/E Ratio
-4,53
P/B Ratio3,43
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -27,50% | Revenue Growth (3Y) | -17,43% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | -4,00% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 31,37M | Net Income (TTM) | -231,96M |
| ROE | -72,19% | ROA | -63,73% |
| Gross Margin | 93,41% | Operating Margin | -775,98% |
| Net Margin | -739,42% | Free Cash Flow (TTM) | -243,39M |
| ROIC | -55,85% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,07 | Current Ratio | 8,88 |
| Interest Coverage | 7376,79 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -4,53 | P/B Ratio | 3,43 |
| P/S Ratio | 33,48 | PEG Ratio | -0,16 |
| EV/EBITDA | N/A | Dividend Yield | 0,00% |
| Market Cap | 1,05B | Enterprise Value | 969,36M |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 31,37M | 43,27M | 46,02M | 41,40M | 36,94M |
| Net Income | -231,96M | -130,87M | -70,80M | -102,25M | -58,42M |
| EPS (Diluted) | -3,17 | -2,32 | -1,82 | -2,74 | -2,03 |
| Gross Profit | 29,31M | 39,56M | 41,39M | 33,08M | 28,76M |
| Operating Income | -243,43M | -145,85M | -75,07M | -99,64M | -55,28M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 364,00M | 418,47M | 355,18M | 180,36M | 263,37M |
| Total Liabilities | 57,88M | 81,96M | 88,86M | 83,99M | 78,99M |
| Shareholders' Equity | 306,11M | 336,50M | 266,32M | 96,37M | 184,38M |
| Total Debt | 20,77M | 21,86M | 4,91M | 46,35M | 39,20M |
| Cash & Equivalents | 101,82M | 99,70M | 281,26M | 95,63M | 178,59M |
| Current Assets | 328,66M | 383,31M | 344,80M | 172,81M | 237,75M |
| Current Liabilities | 37,02M | 49,05M | 63,26M | 34,54M | 23,66M |